Parallel Advisors’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $185K | Sell |
39,852
-6,922
| -15% | -$36.1K | ﹤0.01% | 1210 |
|
|
2025
Q4 | $234K | Sell |
46,774
-2,683
| -5% | -$14K | ﹤0.01% | 1009 |
|
|
2025
Q3 | $251K | Buy |
49,457
+3,980
| +9% | +$17.5K | ﹤0.01% | 948 |
|
|
2025
Q2 | $196K | Buy |
45,477
+4,118
| +10% | +$20.4K | ﹤0.01% | 1024 |
|
|
2025
Q1 | $249K | Buy |
41,359
+6,493
| +19% | +$32.8K | 0.01% | 864 |
|
|
2024
Q4 | $138K | Sell |
34,866
-10,883
| -24% | -$48.7K | ﹤0.01% | 1109 |
|
|
2024
Q3 | $268K | Buy |
45,749
+4,375
| +11% | +$21.6K | 0.01% | 808 |
|
|
2024
Q2 | $178K | Buy |
41,374
+5,243
| +15% | +$25.1K | ﹤0.01% | 912 |
|
|
2024
Q1 | $170K | Buy |
36,131
+21,459
| +146% | +$82.2K | ﹤0.01% | 929 |
|
|
2023
Q4 | $72K | Buy |
14,672
+6,571
| +81% | +$32.2K | ﹤0.01% | 1255 |
|
|
2023
Q3 | $44.2K | Sell |
8,101
-9,780
| -55% | -$78.3K | ﹤0.01% | 1452 |
|
|
2023
Q2 | $166K | Buy |
17,881
+6,199
| +53% | +$52.4K | 0.01% | 865 |
|
|
2023
Q1 | $96K | Sell |
11,682
-1,093
| -9% | -$12.1K | ﹤0.01% | 1076 |
|
|
2022
Q4 | $142K | Sell |
12,775
-306
| -2% | -$3.56K | 0.01% | 851 |
|
|
2022
Q3 | $155K | Buy |
13,081
+727
| +6% | +$11K | 0.01% | 773 |
|
|
2022
Q2 | $189K | Sell |
12,354
-436
| -3% | -$7.84K | 0.01% | 703 |
|
|
2022
Q1 | $273K | Buy |
12,790
+6,219
| +95% | +$134K | 0.01% | 612 |
|
|
2021
Q4 | $155K | Buy |
6,571
+139
| +2% | +$2.98K | 0.01% | 838 |
|
|
2021
Q3 | $129K | Buy |
6,432
+2,341
| +57% | +$48K | 0.01% | 880 |
|
|
2021
Q2 | $82K | Buy |
4,091
+2,439
| +148% | +$52.2K | ﹤0.01% | 1019 |
|
|
2021
Q1 | $35K | Sell |
1,652
-737
| -31% | -$15.8K | ﹤0.01% | 1338 |
|
|
2020
Q4 | $52K | Buy |
2,389
+105
| +5% | +$2.05K | ﹤0.01% | 1077 |
|
|
2020
Q3 | $40K | Sell |
2,284
-29
| -1% | -$540 | ﹤0.01% | 1153 |
|
|
2020
Q2 | $43K | Sell |
2,313
-795
| -26% | -$14.1K | ﹤0.01% | 1103 |
|
|
2020
Q1 | $53K | Sell |
3,108
-215
| -6% | -$4.5K | ﹤0.01% | 919 |
|
|
2019
Q4 | $70K | Sell |
3,323
-167
| -5% | -$3.38K | 0.01% | 923 |
|
|
2019
Q3 | $68K | Sell |
3,490
-273
| -7% | -$5.01K | 0.01% | 864 |
|
|
2019
Q2 | $66K | Buy |
3,763
+2
| +0.1% | +$36 | 0.01% | 801 |
|
|
2019
Q1 | $70K | Buy |
3,761
+2
| +0.1% | +$36 | 0.01% | 727 |
|
|
2018
Q4 | $60K | Buy |
3,759
+679
| +22% | +$10.7K | 0.01% | 696 |
|
|
2018
Q3 | $46K | Buy |
3,080
+1,228
| +66% | +$17.9K | 0.01% | 852 |
|
|
2018
Q2 | $26K | Buy |
1,852
+1,524
| +465% | +$20.2K | ﹤0.01% | 954 |
|
|
2018
Q1 | $4K | Hold |
328
| – | – | ﹤0.01% | 1634 |
|
|
2017
Q4 | $5K | Hold |
328
| – | – | ﹤0.01% | 1582 |
|
|
2017
Q3 | $4K | Hold |
328
| – | – | ﹤0.01% | 1672 |
|
|
2017
Q2 | $4K | Sell |
328
-1,000
| -75% | -$13.3K | ﹤0.01% | 1678 |
|
|
2017
Q1 | $17K | Buy |
1,328
+1,000
| +305% | +$12.8K | ﹤0.01% | 1022 |
|
|
2016
Q4 | $4K | Buy |
+328
| New | +$4.24K | ﹤0.01% | 1443 |
|
Other funds holding MPT
VPM
VCM
WAM
Parallel Advisors's MPT Position: Q1 2026 in Review
Parallel Advisors reduced its Medical Properties Trust (MPT) stake by 15% in Q1 2026, selling an estimated $36.1K and leaving 39,852 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #1210.
Parallel Advisors first reported a position in MPT in Q4 2016 and has held it in 38 quarters since. The position peaked at $273K in Q1 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.
- Parallel Advisors held 39,852 shares of Medical Properties Trust worth $185K as of Q1 2026.
- Parallel Advisors sold 6,922 Medical Properties Trust shares in Q1 2026, an estimated $36.1K.
- Medical Properties Trust made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #1210 holding.
- Parallel Advisors first reported a position in Medical Properties Trust in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's Medical Properties Trust position peaked at $273K in Q1 2022.
- 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.